CITIUS PHARMACEUTICALS INC

CTXR NASDAQ

Weedkiller420

CTXR closed above the 23.6 Fibonacci level and broke thru the descending trendline to close above resistance. Im looking for it to increase up the Fibonacci scale. $1.24, $1.38 and $1.52 in the short term.

TheCryptoChartWhisperer

test

TheThirdHeat

Oversold conditions with bullish divergence signals on the loom after a strong 8-k with optimistic outlooks on Mino-Lok and COVID/ARDS treatment

TheThirdHeat

Nice channel here with CM Slingshot tap.

TheThirdHeat

Good realization of gains on COVID news. New support and good upside to recent highs

PennyStock101

Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. It offers Mino-Lok, a patented solution to treat and salvage infected central venous catheters in patients with catheter related bloodstream infections and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for treatment of...

TheThirdHeat

Also bullish on Stoch & Wooddies CCI

Making_Profit

I was looking at this stock and it have a nice bullish pattern because those candles are above the SMA200 , If the candles keep doing trades above that EMA Line and Above SMA 200 it have a high chance to reach that $1.40. Price Fell after reaching $2.00 that is a good signal of a bounce back if candles stay above SMA 200. MACD looks good for me and the RSI is not...

pantheo

At channel resistance

luistoxkz24

PENNANT/ DESCENDING TRIANGLE ON CTXR. WITH CATALYST AHEAD OF PHASE 3 DATA FOR CATHETER RELATED BLOOD STREAM INFECTION 2H 2020 NASDAQ:CTXR , SHOULD SEE A BREAKOUT FOR A NICE RUN

keifer

Hello, What is CTXR? Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous...

stampsmike

This stock apppears to be skyrocketing with my projected trendline. Buy now while cheap!

mauretto432

CTRX = 50000 LONG from 0.85 TP1 1.5 TP2 2.5 TP3 5$ Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of...

Charlestrad3r

CTXR has shown a nice breakout with heavy volume, followed by a pullback to the crime scene on low volume while RSI hovering just around 50, it is now moving above the 50 MA and breaking out of the second downtrendline, a good risk/reward setup

PennyStock101

Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. It offers Mino-Lok, a patented solution to treat and salvage infected central venous catheters in patients with catheter related bloodstream infections and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for treatment of...

Charlestrad3r

Citius recently Announced Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok® Pivotal Trial Top line data due for 1H 2020 insider Own 42.50% Shs Float 16.64M Market Cap 28.70M Increase in hedge fund holdings

TechnicalAnalysiss

Unusual amount of money in a small relative price range. A bigger, totally move is on the way.